GB2126236B - Production of antibodies - Google Patents
Production of antibodiesInfo
- Publication number
- GB2126236B GB2126236B GB08323455A GB8323455A GB2126236B GB 2126236 B GB2126236 B GB 2126236B GB 08323455 A GB08323455 A GB 08323455A GB 8323455 A GB8323455 A GB 8323455A GB 2126236 B GB2126236 B GB 2126236B
- Authority
- GB
- United Kingdom
- Prior art keywords
- antibodies
- mammal
- production
- vaccine
- hyperimmunising
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000124008 Mammalia Species 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000001018 virulence Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
- A23L11/65—Soy drinks
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Agronomy & Crop Science (AREA)
- Botany (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Antibodies are produced by hyperimmunising a mammal, such as a cow, with a vaccine derived from E. coli bacteria. The bacterial strains in the vaccine are selected on the basis of their virulence characteristics, especially adhesion factors (pili), associated with gastroenteric disease in humans. The antibodies can be recovered from the mammal's milk or serum, and used in human foods.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8225036 | 1982-09-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8323455D0 GB8323455D0 (en) | 1983-10-05 |
GB2126236A GB2126236A (en) | 1984-03-21 |
GB2126236B true GB2126236B (en) | 1986-09-24 |
Family
ID=10532644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08323455A Expired GB2126236B (en) | 1982-09-02 | 1983-09-01 | Production of antibodies |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0102831B1 (en) |
JP (2) | JPS5973528A (en) |
AT (1) | ATE43500T1 (en) |
AU (1) | AU548623B2 (en) |
CA (1) | CA1219806A (en) |
DE (1) | DE3379937D1 (en) |
DK (1) | DK398683A (en) |
GB (1) | GB2126236B (en) |
HK (1) | HK91087A (en) |
IE (1) | IE55673B1 (en) |
NZ (1) | NZ205392A (en) |
ZA (1) | ZA836349B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK219084D0 (en) * | 1984-05-02 | 1984-05-02 | Frederik Carl Peter Lindberg | ANTIGEN |
JPS6399020A (en) * | 1986-06-05 | 1988-04-30 | ベイラ− カレツジ オブ メデイシン | Vaccine and manufacture |
US4725435A (en) * | 1986-06-18 | 1988-02-16 | Bactex, Inc. | Vaccine composition for immunization against urinary tract infection caused by E. coli |
US5106618A (en) * | 1987-07-02 | 1992-04-21 | Stolle Research And Development Corporation | Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product |
AU601510B2 (en) * | 1987-11-06 | 1990-09-13 | Immunomed Corporation | Preparation of bacterium pili subunits and vaccines containing pili subunits |
DE4026365A1 (en) * | 1990-08-21 | 1992-02-27 | Biotest Pharma Gmbh | STERILE FILTERED COLORED MILK |
ATE234855T1 (en) * | 1993-09-20 | 2003-04-15 | Anadis Ltd | METHOD FOR PRODUCING IMMUNOGLOBULINS FROM COLOSTRUM AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS |
ES2076895B1 (en) * | 1994-02-04 | 1996-08-16 | Ind Farma Especial | FIMBRIAS-ADHESINAS OF TYPE 1 AND P ISOLATED FROM NEW STRAINS OF E. COLI, PROCEDURE FOR THEIR OBTAINING AND APPLICATIONS. |
US6471966B1 (en) | 1994-02-04 | 2002-10-29 | Industrial Farmaceutica Y De Especialidades, S.A. | Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof |
US5707678A (en) * | 1995-04-12 | 1998-01-13 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
US5670196A (en) * | 1995-04-12 | 1997-09-23 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
DE19641466A1 (en) * | 1996-10-09 | 1998-04-16 | Biotest Pharma Gmbh | Oral use of an immunoglobulin preparation for the prevention of hemolytic uremic syndrome and a preparation therefor |
JP2006506991A (en) | 2002-11-25 | 2006-03-02 | デン・コンゲリエ・ヴェテリネー−オ・ランボホイスコレ | Pig polymorphism and methods for its detection |
AU2003901008A0 (en) * | 2003-03-04 | 2003-03-20 | Anadis Ltd | Composition for the treatment and prevention of bacterial infections |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1472624A (en) * | 1974-09-02 | 1977-05-04 | Canadian Patents Dev | Enteric disease vaccine |
GB1560934A (en) * | 1975-05-07 | 1980-02-13 | Unilever Ltd | Methods for the resistance of non-human mammals to gastro-intestinal disorders |
JPS5842759B2 (en) * | 1975-05-23 | 1983-09-21 | カブシキガイシヤ バイオリサ−チセンタ− | Cellular Xenoseizouhou |
GB1553664A (en) * | 1975-06-12 | 1979-09-26 | Unilever Ltd | Antigenic compositions |
JPS52120116A (en) * | 1976-04-02 | 1977-10-08 | Kitasato Inst | Domestic animal colitis germ inactevated vaccine |
CH627079A5 (en) * | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
EP0048881B1 (en) * | 1980-09-15 | 1985-08-28 | Bactex Incorporated | Immunization of humans against enterotoxogenic infection by escherichia coli |
JPS5781417A (en) * | 1980-09-15 | 1982-05-21 | Bactex Inc | Human immunity effect imparting vaccine against escherichia coli infectious desease |
JPS5784147A (en) * | 1980-11-13 | 1982-05-26 | Seiko Epson Corp | Manufacture of integrated circuit |
-
1983
- 1983-08-26 NZ NZ205392A patent/NZ205392A/en unknown
- 1983-08-26 ZA ZA836349A patent/ZA836349B/en unknown
- 1983-08-30 AU AU18538/83A patent/AU548623B2/en not_active Ceased
- 1983-08-31 CA CA000435803A patent/CA1219806A/en not_active Expired
- 1983-09-01 EP EP83305051A patent/EP0102831B1/en not_active Expired
- 1983-09-01 DK DK398683A patent/DK398683A/en not_active Application Discontinuation
- 1983-09-01 DE DE8383305051T patent/DE3379937D1/en not_active Expired
- 1983-09-01 GB GB08323455A patent/GB2126236B/en not_active Expired
- 1983-09-01 JP JP58161204A patent/JPS5973528A/en active Pending
- 1983-09-01 IE IE2055/83A patent/IE55673B1/en not_active IP Right Cessation
- 1983-09-01 AT AT83305051T patent/ATE43500T1/en not_active IP Right Cessation
-
1987
- 1987-12-03 HK HK910/87A patent/HK91087A/en not_active IP Right Cessation
-
1989
- 1989-10-25 JP JP1278336A patent/JPH02160726A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA836349B (en) | 1985-04-24 |
DK398683D0 (en) | 1983-09-01 |
GB2126236A (en) | 1984-03-21 |
GB8323455D0 (en) | 1983-10-05 |
IE55673B1 (en) | 1990-12-19 |
EP0102831A1 (en) | 1984-03-14 |
JPS5973528A (en) | 1984-04-25 |
DE3379937D1 (en) | 1989-07-06 |
HK91087A (en) | 1987-12-11 |
CA1219806A (en) | 1987-03-31 |
DK398683A (en) | 1984-03-03 |
AU1853883A (en) | 1984-03-08 |
JPH02160726A (en) | 1990-06-20 |
EP0102831B1 (en) | 1989-05-31 |
NZ205392A (en) | 1987-03-06 |
IE832055L (en) | 1984-03-02 |
ATE43500T1 (en) | 1989-06-15 |
AU548623B2 (en) | 1985-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2126236B (en) | Production of antibodies | |
EP0077734A3 (en) | Production of monoclonal antibodies against bacterial adhesins | |
ATE7201T1 (en) | PROCESS FOR THE MANUFACTURE OF A BACTERIAL PREPARATION FOR THE PREVENTION OF ENTERAL DISORDERS IN POULTRY. | |
GR3005768T3 (en) | ||
EP0299183A3 (en) | Method for increasing the protein contents of milk in ruminants | |
CA2022420A1 (en) | Escherichia coli vaccine | |
NZ212244A (en) | Preparation of cell surface protein of fibronectin binding properties useful as topical anti-infectant and vaccine | |
JPS6485086A (en) | Protein f for outer membrane of pseudomonas aeruginosa | |
FI102544B1 (en) | Method for preparing an E. coli strain | |
EP0299354A3 (en) | Monoclonal antibodies against protein e7 of the human papilloma virus type 16, their production process and their use | |
NO900992D0 (en) | PROCEDURE FOR THE PREPARATION OF A DRINK WITH A PH VALUE OF 3.6 TO 4.2 AND BASED ON ACID MILK. | |
DK145988A (en) | Differential pulley with blocks | |
EP0084522A3 (en) | Plasmids and bacteria strains, and method of preparing the same | |
DE3467626D1 (en) | Storage-stable universal control serum | |
DE3476968D1 (en) | Vaccine and process for its preparation | |
AU7293387A (en) | Process for the treatment of milk for cheesemaking | |
Uradzinski et al. | The influence of heating on the survival of Salmonella sp. in naturally souring milk. | |
Vitkov et al. | Antigenic structural studies of S. aureus strains in mastitis in cows | |
IT9047536A0 (en) | STRAIN OF BACTERIA LACTOBACILLUS CASEI SUBSP. CASEI 37 FOR THE PRODUCTION OF AN ORGANIC BACTERIAL PREPARATION. | |
Varadaraj | Incidences of staphylococci in milk and milk products marketed in India. | |
FR2356727A1 (en) | Staphylococcus aureus endo antigenic extracts - prepd. by treatment of the bacteria with glycine and polyvinyl pyrrolidone | |
Geringer | Investigations on the presence of pathogenic and enterotoxigenic staphylococci in goat milk. | |
Szegli et al. | Gram-negative bacterial infection and acute knee joint arthritis. | |
Seiler | Nutritional requirements of coryneform bacteria and micrococci in the assimilation test. | |
AU7189691A (en) | Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19980901 |